Drug Profile
K1K2Pu
Latest Information Update: 08 Dec 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Anti-ischaemics; Antithrombotics
- Mechanism of Action Plasminogen activator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial infarction; Thrombosis
Most Recent Events
- 08 Dec 1998 No-Development-Reported for Myocardial infarction in Belgium (Unknown route)
- 08 Dec 1998 No-Development-Reported for Thrombosis in Belgium (Unknown route)
- 12 Jun 1995 Investigation in Myocardial infarction in Belgium (Unknown route)